Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand

Εμφάνιση άλλων εκδόσεων (1)

<p style="text-align:justify;">Dihydroartemisinin‐piperaquine is an effective drug in the treatment of Plasmodium falciparum and P. vivax malaria. The objective of this study was to evaluate the population pharmacokinetics and pharmacodynamics of piperaquine in patients with P. viva...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Tarning, J, Thana, P, Phyo, A, Lwin, K, Hanpithakpong, W, Ashley, E, Day, N, Nosten, F, White, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Wiley 2014

Παρόμοια τεκμήρια

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
ανά: Phyo, A, κ.ά.
Έκδοση: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2015)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Quantification of the antimalarial piperaquine in plasma.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Characterization of human urinary metabolites of the antimalarial piperaquine.
ανά: Tarning, J, κ.ά.
Έκδοση: (2006)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria
ανά: Wattanakul, T, κ.ά.
Έκδοση: (2021)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
ανά: Permala, J, κ.ά.
Έκδοση: (2017)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
ανά: White, N
Έκδοση: (2013)

Antimalarial effects of rifampin in Plasmodium vivax malaria.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (1994)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
ανά: Hanboonkunupakarn, B, κ.ά.
Έκδοση: (2014)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
ανά: Phyo, A, κ.ά.
Έκδοση: (2016)

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
ανά: Lohy Das, J, κ.ά.
Έκδοση: (2017)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
ανά: Chotivanich, K, κ.ά.
Έκδοση: (2004)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
ανά: Hoglund, R, κ.ά.
Έκδοση: (2017)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
ανά: Annerberg, A, κ.ά.
Έκδοση: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
ανά: Annerberg, A, κ.ά.
Έκδοση: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
ανά: Bergstrand, M, κ.ά.
Έκδοση: (2014)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (1994)

Chloroquine versus hihydroartemisinin-piperaquine with standard high-dose Primaquine given either for 7 days or 14 days in Plasmodium vivax malaria
ανά: Chu, C, κ.ά.
Έκδοση: (2018)

Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.
ανά: Douglas, N, κ.ά.
Έκδοση: (2011)

POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
ανά: Tarning, J, κ.ά.
Έκδοση: (2010)